PRNewsWire - Health

Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.
Vasa Therapeutics Announces Successful Completion of First-in-Human Study for Investigational Therapy VS-041, a Small Molecule Drug Candidate for Heart Failure with Preserved Ejection Fracture
DRUID AI receives Microsoft certification for AI in Healthcare
Eden Launches Free Digital Wellness Community, Expanding Access to Personalized Fitness and Lifestyle Support